Skip to content

Clinical trials

Gastrointestinal Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Country / region: Belgium Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20131
20161
20172
20181
20191
20203
20211
20222
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Completed5
Recruiting5
Unknown status2
Approved for marketing1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Boehringer Ingelheim2
GlaxoSmithKline2
Jules Bordet Institute2
AstraZeneca1
Baki Topal1
BicycleTx Limited1
Hoffmann-La Roche1
IDRX, Inc., a wholly owned subsidiary of GSK, LLC1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms19
Colorectal Neoplasms7
Neoplasms7
Colonic Diseases6
Digestive System Diseases6
Digestive System Neoplasms6
Gastrointestinal Diseases6
Intestinal Diseases6
Intestinal Neoplasms6
Colonic Neoplasms5

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.